Augustine Asset Management Inc Novartis Ag Transaction History

Augustine Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 12, 2018	SELL	$64.91 - $73.36 $640,661 - $724,063	-9,870 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$70.39 - $84.15 $310,419 - $371,101	4,410 Added 80.77%	9,870 $797,000
Q4 2017 Jan 22, 2018	SELL	$72.33 - $77.64 $224,367 - $240,839	-3,102 Reduced 36.23%	5,460 $458,000
Q3 2017 Oct 23, 2017	BUY	$74.14 - $77.27 $634,786 - $661,585	8,562	8,562 $735,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Augustine Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Augustine Asset Management Inc with notifications on news.